Superworth

Sunshine Biopharma shares outstanding SBFM

Diluted shares outstanding, averaged over each quarter, from 2018.

Latest quarter, to Jun 30, 2025
18K
On a year earlier
+8714.2%
more shares

Sunshine Biopharma had 18K diluted shares outstanding on average in Q2 FY25, the quarter to Jun 30, 2025.

That is 8714.2% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY20248.2K+13715%
FY202360+7%
FY202256n/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY2518K+8714%
Q1 FY2513.5K+8331%
Q4 FY248.2K+13715%
Q3 FY246.3K+9768%
Q2 FY24204−100%
Q1 FY24160+191%
Q4 FY2360+7%
Q3 FY2364+36%
Q2 FY2363.4K+159842%
Q1 FY2355+318%
Q4 FY2256n/a
Q3 FY2247n/a

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Sunshine Biopharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.